Who Owns aTyr Pharma Stock?
NASDAQ: ATYRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 39.83%
- Held by insiders
- 0.31%
- Institutional holders
- 116
- Institutions 39.8%
- Insiders 0.3%
- Public and other 59.9%
Who owns aTyr Pharma stock?
Institutional investors own about 39.8% of aTyr Pharma's shares, spread across 116 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.31% of ATYR.
The largest institutional holders are Federated Hermes, Inc. (8.68%), Vanguard Capital Management LLC (3.88%) and GSA Capital Partners LLP (3.52%). Together, the top 10 institutions control 29.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their ATYR positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ATYR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Federated Hermes, Inc. | 8.51M | 8.68% | -19.0% |
| Vanguard Capital Management LLC | 3.81M | 3.88% | -0.1% |
| GSA Capital Partners LLP | 3.45M | 3.52% | +105.1% |
| AQR Capital Management, LLC | 2.61M | 2.66% | +426.3% |
| FMR, LLC | 2.47M | 2.52% | -83.2% |
| Blackrock Inc. | 1.83M | 1.86% | -71.6% |
| Kalehua Capital Management LLC | 1.79M | 1.82% | +100.0% |
| Jane Street Group, LLC | 1.72M | 1.75% | +3448.9% |
| UBS Group AG | 1.53M | 1.56% | -60.4% |
| Morgan Stanley | 1.34M | 1.37% | +9.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ATYR
| Fund | Shares | % Held |
|---|---|---|
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund | 4.37M | 4.45% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 4.06M | 4.14% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.65M | 2.70% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.75M | 1.79% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.05M | 1.08% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 508.08K | 0.52% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 488.82K | 0.50% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 168.12K | 0.17% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 145.36K | 0.15% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Growth Index Fund | 85.88K | 0.09% |
Frequently asked questions
Who is the largest shareholder of aTyr Pharma?
Federated Hermes, Inc. is the largest institutional shareholder of ATYR, owning 8.68% of shares outstanding (8.51M shares) as of its latest 13F filing.
What percentage of aTyr Pharma is owned by institutions?
Institutions own about 39.8% of ATYR shares and 40.0% of the public float.
How much of aTyr Pharma do insiders own?
Insiders, such as officers and directors, own about 0.31% of ATYR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.